Ceftriaxone-induced Acute Cholecystitis
- PMID: 35127411
- PMCID: PMC8772462
- DOI: 10.4103/JMU.JMU_132_20
Ceftriaxone-induced Acute Cholecystitis
Abstract
Ceftriaxone has been increasingly used in pediatric population, due to its bacteriological and pharmacokinetic features. Association between ceftriaxone and biliary sludge/pseudolithiasis formation has been documented in the literature. More rarely, biliary symptoms and cholecystitis during ceftriaxone therapy have been reported. We present a case of acute cholecystitis related to ceftriaxone administration and its management.
Keywords: Ceftriaxone; cholecystitis; cholecystolithiasis; contraindications; drug-induced.
Copyright: © 2021 Journal of Medical Ultrasound.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Ozturk A, Kaya M, Zeyrek D, Ozturk E, Kat N, Ziylan SZ. Ultrasonographic findings in ceftriaxone: Associated biliary sludge and pseudolithiasis in children. Acta Radiol. 2005;46:112–6. - PubMed
-
- Biner B, Öner N, Çeltik C, Bostancioğlu M, Tunçbilek N, Güzel A, et al. Ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound. 2006;34:217–22. - PubMed
-
- Blais C, Duperval R. Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy. Pediatr Radiol. 1994;24:218–9. - PubMed
-
- Oggiano AM, Clemente MG, Cuzzolin L. Pharmacological treatment of ceftriaxone-related cholelithiasis in children: Is it worthwhile? J Pediatr Neonatal Individ Med. 2019;8:e080108.
Publication types
LinkOut - more resources
Full Text Sources